Sex-Related Difference in Outcomes of Remote Ischemic Conditioning for Symptomatic Intracranial Atherosclerotic Stenosis
- PMID: 40485997
- PMCID: PMC12141781
- DOI: 10.34133/cbsystems.0275
Sex-Related Difference in Outcomes of Remote Ischemic Conditioning for Symptomatic Intracranial Atherosclerotic Stenosis
Abstract
Remote ischemic conditioning (RIC) is a novel and promising therapeutic intervention for symptomatic intracranial atherosclerotic stenosis (sICAS). This study aimed to evaluate sex differences in stroke recurrence among patients with sICAS and assess the efficacy of RIC in the RICA (chronic remote ischemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis) trial. The RICA trial was a multicenter, randomized clinical trial conducted across 84 stroke centers in China. Patients with sICAS were randomly assigned on a 1:1 ratio to receive either RIC intervention or sham RIC intervention once daily for 12 months. The primary endpoint was ischemic stroke recurrence. The median follow-up duration was 3.5 years. Of the 3,033 patients enrolled in the RICA trial, 1,079 (35.58%) were women. Female patients were generally older (mean [SD] age 62.9 [8.8] years versus 60 [9.2] years) and had a higher prevalence of hypertension, diabetes, and a higher body mass index than male patients. No significant difference was observed in ischemic stroke recurrence risk between female and male patients during a median follow-up of 3.5 years (20.5% versus 16.6%, adjusted hazard ratio, 1.18; [95% CI, 0.97 to 1.42]). However, RIC significantly reduced the risk of ischemic stroke recurrence in male patients, while no similar effect was observed in female patients (adjusted hazard ratio, 0.88; [95% CI, 0.58 to 1.32]; P for interaction = 0.379). No significant sex-based differences were observed in ischemic stroke recurrence among patients with sICAS over the 3.5-year follow-up period. RIC may have better therapeutic benefits for male patients with good compliance.
Copyright © 2025 Yuanyuan Liu et al.
Conflict of interest statement
Competing interests: The authors declare that they have no competing interests.
Figures


Similar articles
-
Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China.Lancet Neurol. 2022 Dec;21(12):1089-1098. doi: 10.1016/S1474-4422(22)00335-0. Epub 2022 Oct 27. Lancet Neurol. 2022. PMID: 36354026 Clinical Trial.
-
Remote ischemic conditioning improves cerebral hemodynamics in symptomatic intracranial atherosclerosis: A PET/CT-guided randomized controlled study.J Neurosci Res. 2024 Mar;102(3):e25324. doi: 10.1002/jnr.25324. J Neurosci Res. 2024. PMID: 38515341 Clinical Trial.
-
Remote limb ischemic conditioning treatment for intracranial atherosclerotic stenosis patients.Int J Stroke. 2016 Oct;11(7):831-8. doi: 10.1177/1747493016654489. Epub 2016 Jun 16. Int J Stroke. 2016. PMID: 27312678 Clinical Trial.
-
Efficacy and safety of remote ischemic conditioning for acute ischemic stroke: A comprehensive meta-analysis from randomized controlled trials.CNS Neurosci Ther. 2023 Sep;29(9):2445-2456. doi: 10.1111/cns.14240. Epub 2023 May 14. CNS Neurosci Ther. 2023. PMID: 37183341 Free PMC article. Review.
-
Remote Ischemic Conditioning With Medical Management or Reperfusion Therapy for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.Neurology. 2024 Apr 9;102(7):e207983. doi: 10.1212/WNL.0000000000207983. Epub 2024 Mar 8. Neurology. 2024. PMID: 38457772 Free PMC article.
Cited by
-
Non-traditional lipid parameters are independent predictors of the location, distribution, and stroke events of moderate-to-severe intracranial and extracranial atherosclerotic stenosis.Front Neurol. 2025 Jul 9;16:1564966. doi: 10.3389/fneur.2025.1564966. eCollection 2025. Front Neurol. 2025. PMID: 40703776 Free PMC article.
References
-
- Gray LJ, Sprigg N, Bath PMW, Boysen G, De Deyn PP, Leys D, O’Neill D, Ringelstein EB, TAIST Investigators . Sex differences in quality of life in stroke survivors: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke. 2007;38(11):2960–2964. - PubMed
-
- Glader E-L, Stegmayr B, Norrving B, Terént A, Hulter-Asberg K, Wester P-O, Asplund K, Riks-Stroke Collaboration . Sex differences in management and outcome after stroke: A Swedish national perspective. Stroke. 2003;34(8):1970–1975. - PubMed
LinkOut - more resources
Full Text Sources